The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey

Since the introduction of Cetuximab as a biological molecule against Epidermal Growth Factor Receptor (EGFR), its use in the cancers of head and neck region is widely explored. With the recognition that EGFR expression is associated with radioresistance and poor prognosis, incorporation of an anti-E...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnamurthy, Sapna, Ahmed, Imtiaz, Bhise, Rohan, Mohanti, Bidhu K, Sharma, Atul, Rieckmann, Thorsten, Paterson, Claire, Bonomo, Pierluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958314/
https://www.ncbi.nlm.nih.gov/pubmed/35356388
http://dx.doi.org/10.1016/j.ctro.2022.03.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958314/
https://www.ncbi.nlm.nih.gov/pubmed/35356388
http://dx.doi.org/10.1016/j.ctro.2022.03.009

Ejemplares similares